Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone versus placebo after final height in Prader-Willi syndrome transition
2007-004716-31Phase 4Completed
- Sponsor
- Dutch Growth Research Foundation
- Start
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, double-blind trial of somatropin in Prader-Willi syndrome (PWS) (2 arms), sponsored by Dutch Growth Research Foundation. Primary endpoints: Weight, Body composition by DXA and 4 more. Started Nov 2007; status: completed.
02
Drugs
somatropin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on 2007-004716-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004716-31.